Evoq Remedies share news, announcements and annual reports
BSE: 543500Commercial Services & SuppliesSmall Cap
Evoq Remedies Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 2022
Last close ₹1.63₹0.00 (0.00%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹1.63.
30 Oct: open ₹1.63, high ₹1.63, low ₹1.63
52-week range of traded prices to 30 Oct 2026
₹1.35Low, 22 Sep 2026₹5.16High, 30 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹4.06 Cr4,812th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.09
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −0.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 8,000
Evoq Remedies share news and announcements
167 announcements, routine notices left out, newest first. Page 4 of 4.
Sep 2022
5 Sep · Legal
Exchange has sought clarification from Evoq Remedies Ltd on September 5, 2022, with reference to Movement in Price. The reply is awaited.3 Sep · Reg. 34 (1) Annual Report.
3 Sep · Board meeting
3 Sep · Board meeting
Jul 2022
19 Jul · Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
May 2022
23 May · Board meeting
Meeting on 30 May 2022: audited results
Apr 2022
30 Apr · Submission Of Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended On 31St March, 2022
6 Apr · Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Mar 2022
30 Mar · Listing of equity shares of Evoq Remedies Ltd
Trading Members of the Exchange are hereby informed that effective from March 30, 2022, the equity shares of Evoq Remedies Ltd (Scrip Code: 543500) are listed and admitted to dealings on ....